Morgan Stanley Immunome Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Immunome Inc. stock. As of the latest transaction made, Morgan Stanley holds 289,078 shares of IMNM stock, worth $3.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

289,078

Previous 371,958 22.28%

Holding current value

$3.46 Million

Previous $4.5 Million 6.09%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $16.51 $969,695 - $1.37 Million	-82,880 Reduced 22.28%	289,078 $4.23 Million
Q2 2024 Oct 17, 2024	BUY	$11.54 - $22.11 $2.57 Million - $4.92 Million	222,561 Added 148.97%	371,958 $4.5 Million
Q2 2024 Aug 14, 2024	BUY	$11.54 - $22.11 $2.57 Million - $4.92 Million	222,561 Added 148.97%	371,958 $4.5 Million
Q1 2024 Oct 17, 2024	SELL	$11.01 - $27.34 $2.45 Million - $6.08 Million	-222,561 Reduced 59.83%	149,397 $3.69 Million
Q1 2024 Aug 16, 2024	BUY	$11.01 - $27.34 $1.51 Million - $3.75 Million	137,242 Added 1129.1%	149,397 $3.69 Million
Q1 2024 May 15, 2024	BUY	$11.01 - $27.34 $1.51 Million - $3.75 Million	137,242 Added 1129.1%	149,397 $3.69 Million
Q4 2023 Aug 16, 2024	SELL	$7.3 - $10.73 $2.63 Million - $3.86 Million	-359,803 Reduced 96.73%	12,155 $130,000
Q3 2023 Nov 15, 2023	SELL	$6.17 - $9.16 $8,088 - $12,008	-1,311 Reduced 9.74%	12,155 $101,000
Q2 2023 Aug 14, 2023	BUY	$4.7 - $7.91 $6,279 - $10,567	1,336 Added 11.01%	13,466 $106,000
Q4 2022 Feb 14, 2023	SELL	$2.21 - $5.0 $8 - $20	-4 Reduced 0.03%	12,130 $26,000
Q3 2022 Nov 14, 2022	SELL	$3.39 - $6.14 $2,698 - $4,887	-796 Reduced 6.16%	12,134 $53,000
Q2 2022 Oct 27, 2022	SELL	$2.24 - $5.79 $1,796 - $4,643	-802 Reduced 5.84%	12,930 $41,000
Q2 2022 Aug 15, 2022	SELL	$2.24 - $5.79 $1,796 - $4,643	-802 Reduced 5.84%	12,930 $41,000
Q1 2022 Oct 27, 2022	BUY	$3.88 - $13.99 $3,111 - $11,219	802 Added 6.2%	13,732 $78,000
Q1 2022 May 13, 2022	SELL	$3.88 - $13.99 $252,134 - $909,112	-64,983 Reduced 82.55%	13,732 $78,000
Q4 2021 Feb 14, 2022	BUY	$12.96 - $23.44 $837,591 - $1.51 Million	64,629 Added 458.82%	78,715 $1.02 Million
Q3 2021 Nov 15, 2021	BUY	$12.5 - $27.76 $176,075 - $391,027	14,086 New	14,086 $343,000

Others Institutions Holding IMNM

# of Institutions

121

Shares Held

47.1M

Call Options Held

322K

Put Options Held

1.91M

View Full List

About Immunome Inc.

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $145M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

More about IMNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account